高迁移率族蛋白B1 巨噬细胞转移抑制因子联合CXC亚家族趋化因子16对高危型HPV感染患者诊断价值

doi:10.3969/j.issn.1006-6233.2024.07.019

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1369 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To investigate the expression levels and diagnostic value of high-mobility group box 1 protein (HMGB1), macrophage migration inhibitory factor (MIF), and CXC chemokine subfamily 16 (CXCL16) in patients with high-risk human papillomavirus (HPV) infection. Methods: A total of 150 patients with HPV infection admitted to our hospital from October 2020 to October 2023 were enrolled in the study group and divided into high-risk HPV infection group (n=40) and low-risk HPV infection group (n=110) according to the results of nucleic acid detection. Another 100 healthy women who underwent transvaginal colposcopy in our hospital during the same period were selected as the control group. The HPV-DNA genotyping kit was used to detect HPV in the study group patients; enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of HMGB1 and CXCL16 in the study group and control group; and immunohistochemistry was used to detect the staining intensity of MIF. The differences in HMGB1, MIF, and CXCL16 between the control group and the study group were compared; the differences in HMGB1, MIF, and CXCL16 between the low-risk HPV infection group and the high-risk HPV infection group were compared; receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic value of HMGB1, MIF, and CXCL16 combined detection for high-risk HPV infection; Spearman correlation analysis was used to analyze the correlation between HMGB1, MIF, and CXCL16 and different HPV infection genotypes. Results: Compared with the control group, the levels of serum HMGB1 and CXCL16, and the score of MIF positive cell proportion in the study group were significantly higher (all P<0.05); compared with the low-risk HPV infection group, the levels of serum HMGB1 and CXCL16, and the score of MIF positive cell proportion in the high-risk HPV infection group were significantly higher (all P<0.05); ROC curve analysis showed that the AUC of HMGB1, MIF, and CXCL16 for the diagnosis of high-risk HPV infection alone and in combination were 0.748, 0.684, 0.791, and 0.934, respectively. The diagnostic value of combined detection was significantly higher than that of single detection (Z=2.577, 3.152, 2.096, all P<0.05); Spearman correlation analysis showed that HMGB1, MIF, and CXCL16 were significantly positively correlated with different HPV infection genotypes (r=0.615, 0.633, 0.649, all P<0.05). Conclusion: The levels of serum HMGB1 and CXCL16, and the score of MIF positive cell proportion in patients with high-risk HPV infection were significantly higher than those in the low-risk and control groups. The combined detection of HMGB1, MIF, and CXCL16 in clinical examination can improve the clinical diagnosis rate of high-risk HPV infection and provide a new detection method and treatment basis for clinical practice.

Key words： Human papillomavirus Genotyping Infection High-mobility group box 1 protein Macrophage migration inhibitory factor CXC chemokine subfamily 16

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CAI Rongrong
	SHI Pingping
	GU Chunyan

Cite this article:

CAI Rongrong,SHI Pingping,GU Chunyan. Combined Detection of High-Mobility Group Box 1 Protein Macrophage Migration Inhibitory Factor (MIF) and CXC Chemokine Subfamily 16 for the Diagnosis of High-Risk Human Papillomavirus Infection[J]. HeBei Med, 2024, 30(7): 1160-1165.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2024.07.019 OR http://www.hbyxzzs.cn/EN/Y2024/V30/I7/1160